Drug Profile
LIB 01
Alternative Names: DIC-2024; LIB-01; Libiguin®; Libiguin® DIC2024Latest Information Update: 29 Sep 2023
Price :
$50
*
At a glance
- Originator Uppsala University
- Developer Dicot
- Class Erectile dysfunction therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Erectile dysfunction; Premature ejaculation